Corvus Pharmaceuticals Inc (NASDAQ:CRVS)

3.56
Delayed Data
As of 3:59pm ET
 +0.03 / +0.85%
Today’s Change
3.20
Today|||52-Week Range
10.04
-3.00%
Year-to-Date
No recent news for Corvus Pharmaceuticals Inc.

Today’s Trading

Previous close3.53
Today’s open3.53
Day’s range3.51 - 3.64
Volume111,928
Average volume (3 months)180,542
Market cap$109.9M
Data as of 3:59pm ET, 09/20/2019

Growth & Valuation

Earnings growth (last year)+37.27%
Earnings growth (this year)+6.58%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.99

Competitors

 Today’s
change
Today’s
% change
NBSENeuBase Therapeutics...+0.35+5.61%
ATXIAvenue Therapeutics ...+0.13+2.15%
SVRASavara Inc+0.12+4.94%
ALNAAllena Pharmaceutica...+0.07+1.66%
Data as of 3:59pm ET, 09/20/2019

Financials

Next reporting dateNovember 4, 2019
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$0.00
Annual profit (last year)-$46.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Richard A. Miller
CFO &
Principal Accounting Officer
Leiv Lea
Corporate headquarters
Burlingame, California

Forecasts